FDA to authorize the use of the Pfizer COVID-19 vaccine for those ages 12-15 as early as next week, The New York Times reports

  • The FDA is set to authorize the use of the Pfizer-BioNTech COVID-19 vaccine for those ages 12-15 by next week, NYT reports.
  • Pfizer announced in late March that their vaccine was highly effective in a trial of more than 2,000 adolescents.
  • See more stories on Insider’s business page.

The Food and Drug Administration is set to authorize the use of the Pfizer-BioNTech COVID-19 vaccine for adolescents aged 12-15 years old as early as next week, The New York Times reported Monday.

Following FDA authorization, an advisory panel from the Centers for Disease Control and Prevention will review data and results from clinical trials to draft recommendations on the use of the vaccine for those 12-15 years old, according to The Times report.

Pfizer announced in late March that their vaccine was highly effective in a trial of more than 2,000 adolescents, and the vaccine was “well tolerated” among those ages 12 to 15.

This story is breaking. Check back for updates.

A picture of a switch and lightbulb
Source: Read Full Article